Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H32Cl2N2O5S |
Molecular Weight | 591.546 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C2=CSC(NC(=O)C3=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C3)=N2
InChI
InChIKey=NOZIJMHMKORZBA-KJCUYJGMSA-N
InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1
Molecular Formula | C29H32Cl2N2O5S |
Molecular Weight | 591.546 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:04:29 UTC 2023
by
admin
on
Sat Dec 16 18:04:29 UTC 2023
|
Record UNII |
6LL5JFU42F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B02BX07
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5059
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
CHEMBL2107831
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
MULPLETA
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | APPROVED SEPTEMBER 2015 | ||
|
SUB183903
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
ZZ-110
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
49843517
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
DB13125
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
2054984
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
Lusutrombopag
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
DTXSID701027951
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
6LL5JFU42F
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
1110766-97-6
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
C166948
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
100000170082
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
m12103
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
6LL5JFU42F
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY | |||
|
9410
Created by
admin on Sat Dec 16 18:04:31 UTC 2023 , Edited by admin on Sat Dec 16 18:04:31 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
MINOR
|
||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
MINOR
|
||
|
TARGET -> INHIBITOR |
MINOR
|
||
|
TARGET -> INHIBITOR |
MINOR
|
||
|
TARGET -> SUBSTRATE | |||
|
BINDER->LIGAND |
|
||
|
TARGET -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
MINOR
|
||
|
TARGET -> INHIBITOR |
MINOR
|
||
|
TARGET -> AGONIST |
IC50
|
||
|
TARGET -> INHIBITOR |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
DOSE |
|
||